Developing a novel oral antibiotic to treat multidrug-resistant gonorrhea

 

Developing a novel oral antibiotic to treat multidrug-resistant gonorrhea

About CARB-X CARB-X is a consortium led by Boston University and funded by a global partnership. CARB-X is investing up to $500 million from 2016 to 2021 to support the development of innovative …

More Developing a novel oral antibiotic to treat multidrug-resistant gonorrhea Videos

Leave a Reply